Your brain cells are dying. So are mine. Nerve cells in our brains die off throughout our lifetime, from youth to old age, and usually it doesn't make much difference at all in our daily lives. But when brain cells begin to die off prematurely and en masse, the result can be diseases like Alzheimer's and Parkinson's, or the less-dramatic but often equally tragic senile dementia.
When it comes to fat, there’s one type you don’t want to cut back on: omega-3 fatty acids. Two crucial ones -- EPA and DHA -- are primarily found in certain fish. ALA, another omega-3 fatty acid, is found in plant sources such as nuts and seeds. Not only does your body need these fatty acids to function, but also they deliver some big health benefits.
Scientists now are working to understand how cells tell themselves to die, and why it happens sooner in people with degenerative brain diseases. Answers to these questions, they predict, may lead not just to treatments but to cures for these diseases that affect memory or the ability to function normally. But, those answers may still be a long way off.
In the meantime, another area of memory research is edging much closer to the finish line, with potential treatments -- if not outright cures -- tantalizingly close. This is the science of brain plasticity, or how the brain learns and stores new experiences. Tim Tully, PhD, predicts that research into brain plasticity will yield treatments for some memory-robbing diseases within the next two to five years. Tully is a founder of the privately held Helicon Therapeutics, based in Farmingdale, N.Y., and a researcher at Cold Spring Harbor Laboratories.
Switching on a 'Memory Gene'
"We've been working on one particular gene called CREB, which seems to be an important 'switch' for a [nerve cell] to decide when to form long-term memory," Tully explains. "When you experience something new, it activates a circuit in your brain [that turns on CREB]." CREB, he explains, acts like a "general contractor of the brain," organizing and directing the growth processes that strengthen the connections among nerve cells in a particular circuit of the brain. "This, we believe, is [how we form ] long-term memory."
If scientists can develop drugs that stimulate CREB, then they could strengthen the formation of long-term memories in people with diseases like Alzheimer's. "It's not going to cure [the] cell death [that caused the problem], but it'll turn up the memory formation process in the surviving [brain cells] so that the person can function better during the course of the disease," Tully explains.